Ninety-six caucasian both-gender patients with haematomas and/or subcutaneous haematic extravasation of traumatic or surgical origin were randomized to receive local treatment (max 10 days) with heparan sulfate cream or glycosaminoglycan-polysulphate (GAGPS) gel. Signs (oedema, disability, and colour of the lesion) and symptoms (pain at rest and at movement) (scored 0-3), the sum of the scores (primary end point), and the size of the lesion were evaluated at the baseline visit and afterwards every 5 days. The rate of the patients completely healed at the end of the study was also recorded. The results of the study showed that heparan sulfate 1% cream was comparable or superior to GAGPS gel in relieving signs and symptoms. No AEs were recorded.
Keyphrases
- end stage renal disease
- double blind
- spinal cord injury
- ejection fraction
- randomized controlled trial
- newly diagnosed
- wound healing
- chronic kidney disease
- clinical trial
- mental health
- chronic pain
- multiple sclerosis
- peritoneal dialysis
- pain management
- placebo controlled
- depressive symptoms
- hyaluronic acid
- phase ii
- neuropathic pain
- combination therapy
- african american
- patient reported
- smoking cessation
- replacement therapy